StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Company email’s

<< Previous

Bullboard Posts

Next >>

Comment by Boomer51on Nov 08, 2022 8:47pm

108 Views

Post# 35083978

RE:RE:RE:Company email’s

Totally agree Brad I.. I'm not complaining.i am not a big shareholder.10k common shares and 200,000 warrants.wt at 4 cents unfortunately common shares at 1.08 so at this point because of no lnformation I'm looking g to right it off..wt. warrents expire end of June does not look good.im looking at approximate 20k lost such is Penny stocks if you get in brother's grin and bear it .It was your decision will live with ot

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario